Retifanlimab improves progression-free survival in advanced squamous cell anal carcinoma
1. Progression-free survival was significantly greater in retifanlimab compared to placebo. 2. Serious and grade 3 or more adverse events ...
Tag: Anal Cancer
Expanding human papillomavirus vaccination to high-risk mid-adults may be cost-effective
1. In this modeling study, the cost-effectiveness and number needed to vaccinate of mid-adult human papillomavirus (HPV) vaccination improved when ...
Treatment of anal high-grade squamous intraepithelial lesions can reduce rates of progression to invasive anal cancer.
1. The rate of progression was 57% lower in the group receiving anal HSIL treatment as compared to the group ...
Patient Basics: Anal Cancer
Originally published by Harvard Health. What Is It? Anal cancer is an uncontrolled growth of abnormal cells in the anus. ...
